Mycotoxin Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Aflatoxin, Deoxynivalenol, Ochratoxins, Fumonisins, Others), By Technology (HPLC-based, LC-MS/MS-based, Immunoassay-based, Others), By Sample (Food, Feed), By End User (Research Lab, Research Institutes, Food Testing Industries, Feed Testing Industries and Others), By Region and Competition, 2019-2029F

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 1247.19 Million

Market Size (2029)

USD 1922.88 Million

CAGR (2024-2029)

7.56%

Fastest Growing Segment

Aflatoxin

Largest Market

Europe

Market Overview

Global Mycotoxin Testing Market was valued at USD 1247.19 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.56% through 2029. Mycotoxin is a highly toxic secondary metabolite classified as such. It is produced by microorganisms belonging to the fungi group. Consumption of mycotoxin can lead to fatality or result in severe medical concerns for both animals and humans. Due to their aerobic nature, mycotoxins can be found anywhere, relying on organic matter in humid environments with suitable temperatures. Under favorable conditions, fungi exponentially grow and form colonies, leading to an increased presence of mycotoxins. Despite years of research, the exact reason for their presence remains unknown, but they are predominantly found in food products. The presence of mycotoxins weakens the chemical properties of the host, and even small quantities at the initial stage can promote fungal proliferation. The growth of mycotoxins depends on both the extrinsic and intrinsic environment, and the toxic content can vary significantly based on the host's metabolism, susceptibility, and immunity. Mycotoxin testing is mandatory for businesses operating in the food and industry sector, regardless of their size, as international and regional regulatory bodies maintain strict standards for circulating food content in the economy.

Key Market Drivers

Increase in the Prevalence of Foodborne Disease

The increase in the prevalence of foodborne diseases is one of the key factors boosting the demand for mycotoxin testing. Mycotoxins are naturally occurring toxic compounds produced by molds that can contaminate various food products. When consumed, these mycotoxins can lead to a range of health issues, including food poisoning, organ damage, and even long-term health effects. The rising occurrence of foodborne diseases attributed to mycotoxin contamination has led to a heightened demand for mycotoxin testing. As medical and scientific understanding improves, more cases of foodborne illnesses are being accurately diagnosed and attributed to specific pathogens or contaminants. This includes identifying mycotoxins as causative agents in outbreaks. When outbreaks occur, it triggers investigations into the sources of contamination, highlighting the need for stringent mycotoxin testing to prevent future incidents. The increase in the prevalence of foodborne diseases linked to mycotoxin contamination has led to a greater demand for mycotoxin testing. As the health risks become more evident and regulations continue to tighten, the food industry is recognizing the importance of proactive mycotoxin testing to ensure the safety and quality of food products.

Accelerating Need for Food Safety

The accelerating need for food safety has significantly boosted the demand for mycotoxin testing. Mycotoxins are toxic compounds produced by certain molds that can contaminate various agricultural products, including grains, nuts, spices, and fruits. These contaminants pose serious health risks to humans and animals when consumed in food and feed. As awareness of foodborne illnesses and their potential consequences has grown, the importance of mycotoxin testing has increased, leading to a higher demand for these testing services and technologies. armers and agricultural producers are increasingly adopting mycotoxin testing as a proactive risk management strategy. By identifying potential mycotoxin issues early in the supply chain, they can take appropriate measures to prevent mold growth and contamination, ensuring higher-quality yields and minimizing economic losses. Consumers have become increasingly aware of the presence of mycotoxins in products, leading to a significant rise in demand. This heightened awareness acts as a driving force behind the growth of the Mycotoxin Testing Market. The utilization of advanced technologies for efficient and rapid mycotoxin testing further contributes to the market's expansion.

Stringent Regulations Laid by The Government on Implementation of Testing

Governments and regulatory bodies worldwide have implemented mandatory testing of animal feed and food ingredients. The approval for marketing animal feed is contingent upon demonstrating its safety and efficacy. These precautionary measures, aimed at preventing contamination, chemical presence, and toxicity, have had a significant impact on the growth of the mycotoxin testing market. To safeguard human and animal health, numerous countries have established specific regulations regarding mycotoxins in food and animal feed. The global mycotoxin testing market is poised for growth due to the escalating analysis and stringent regulations pertaining to animal feed content in the local market. Consumption of mycotoxin in animals can give rise to a range of severe medical conditions, including alimentary toxic aleukia, hemorrhagic syndromes, hepatic diseases, nephropathy, neurological disorders, immunological abnormalities, and various types of cancer. Therefore, it is imperative for animal feed providers to conduct mycotoxin testing, ensuring comprehensive proof of the precise content present in the animal feed before it is introduced in the market for sale. To facilitate this process, mycotoxin test providers have introduced a variety of at-home and rapid tests, offering instant results. The availability of these tests enables individuals to conveniently conduct the tests themselves, obviating the need for external reports. These factors are expected to further propel the growth of the global market, as more people gain access to convenient testing options.

Rise in Global Food Trade

With the expansion of global trade and complex food supply chains, products can now be sourced from different parts of the world. This increases the potential for mycotoxin contamination as products move through various stages of production, transportation, and storage. Rigorous mycotoxin testing helps prevent contaminated products from entering the market and spreading through international supply chains.

The global food trade has experienced significant growth in recent years and is projected to continue expanding in the future. Both developed and developing nations have become increasingly involved in global food trade, acting as importers, exporters, or both. This growth is driven by rising consumer demand for a wide range of tasty and readily available food products throughout the year. The trade of processed food products is expected to outpace the trade of agricultural commodities, as it addresses the growing need for food safety and security. Concerns about food safety and quality have gained prominence due to heightened awareness of health issues associated with food contamination. Consequently, there is a greater demand for food testing services, including mycotoxin testing.


Download Sample Report

Key Market Challenges

Lack of Infrastructure to Restrict Market Expansion

Many underdeveloped or developing nations face challenges in establishing the infrastructure necessary for conducting mycotoxin testing. Limited access to advanced technology hinders these economies, leading to potential non-compliance with regulations that can significantly impact global market growth. This applies to both domestic and multinational firms, as they may refrain from investing in the required testing systems. The lack of awareness among the general population about the harmful effects of consuming mycotoxins further contributes to corporations evading such tests. Factors such as inadequate management, outdated information, and limited expertise in regional law and regulation can also impede global market expansion during the projected period.

Lack of Qualified Personnel

The global market is experiencing a substantial demand for qualified technical personnel to perform mycotoxin testing and cover related areas. However, there exists a significant disparity between the demand for certified professionals and the actual supply. This poses a challenge for market players as they face increased pressure to provide timely and updated information in compliance with regional laws and regulations.

Key Market Trends

Expansion Opportunities in Emerging Markets

Increasing food trade across borders in emerging markets presents opportunities for market growth. The rising prevalence of food-borne illnesses and inadequate sanitation and processing conditions in certain countries, like Indonesia, underscores the necessity for mycotoxin testing of food. China, as a prominent food-importing and -exporting nation, plays a pivotal role in the mycotoxin testing market. The implementation of regulations in emerging economies engaged in food trade, empowering authorities to prohibit the import and supply of contaminated food, enforce food recalls, and mandate nutrition labeling, is anticipated to drive the demand for testing services in these regions. The escalating occurrences of mycotoxicosis outbreaks in the emerging economies of Asia and Africa present significant growth prospects for mycotoxin testing in these areas. Developing countries are consistently exposed to high levels of aflatoxins, fumonisins, and trichothecenes, which are known to cause carcinogenicity, immunotoxicity, and growth retardation in animals. Multiple studies conducted in Nigeria have reported toxin levels far exceeding the limits set by international regulatory agencies in food and agricultural products. There have been widespread reports of fatal outbreaks of toxicities, particularly due to aflatoxins, in Nigeria. Addressing the food safety and international trade concerns associated with mycotoxin contamination in Nigerian consumer goods and agricultural products is of utmost urgency. Developing countries like Nigeria face significant challenges due to a lack of organized scientific information and data on the magnitude of the problem.

Growing Consumer Awareness

The global mycotoxin testing market is expected to experience significant growth due to the increasing number of consumers who are cognizant of the impact of food ingredients on their health. This awareness is facilitated by the availability of information on the internet and the proactive efforts of regional health departments in educating the public about the risks associated with consuming harmful compounds. As consumer awareness continues to grow, corporations are compelled to provide accurate information to attract new customers and preserve brand value.

Segmental Insights

Type Insights

Based on Type, the market is divided into Aflatoxin, Deoxynivalenol, Ochratoxins, Fumonisins, and Others. Aflatoxins dominated the Global Mycotoxin Testing Market due to several factors that highlight their significance in food safety and regulatory compliance. Aflatoxins are highly toxic secondary metabolites produced by certain fungi, primarily Aspergillus species, which commonly contaminate food and feed crops such as maize, peanuts, and tree nuts. These toxins pose severe health risks to humans and animals, including carcinogenic, mutagenic, and immunosuppressive effects, making their detection and regulation paramount in ensuring public health and food safety. One of the key reasons for the dominance of aflatoxins in the mycotoxin testing market is their widespread occurrence and persistence in agricultural commodities across the globe. Aflatoxin contamination is prevalent in regions with warm and humid climates, where conditions favor fungal growth and toxin production. As a result, aflatoxin contamination poses a significant challenge to food producers, processors, and regulatory authorities worldwide, necessitating robust testing protocols and monitoring programs to mitigate risks to human and animal health.

Aflatoxins have garnered considerable attention from regulatory agencies and international organizations due to their potent toxicity and adverse health effects. Regulatory bodies such as the Food and Drug Administration (FDA), European Food Safety Authority (EFSA), and World Health Organization (WHO) have established strict regulatory limits and guidelines for aflatoxin levels in food and feed products, mandating routine testing and compliance measures by food manufacturers, importers, and exporters.

Technology Insights

Based on technological advancements, the global market is categorized into immunoassay-based, high-performance liquid chromatography, liquid chromatography with tandem mass spectrometry (LC-MS/MS), and other segments. The high-performance liquid chromatography (HPLC) segment is anticipated to emerge as the fastest-growing segment within the global market, driven by its exceptional capability to precisely quantify plasma levels of drugs and their metabolites. In the realm of medical diagnostics and pharmaceutical research, the accuracy of diagnosis and treatment efficacy hinges upon the precise determination of concentrations of biogenic substances within biological samples. Herein lies the strength of HPLC, which enables healthcare professionals and researchers to obtain highly accurate and reliable measurements of analytes in complex sample matrices.

The adoption of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) has witnessed remarkable growth, emerging as one of the most potent analytical techniques in the field. LC-MS/MS seamlessly integrates the capabilities of liquid chromatography with the sensitivity and selectivity of triple quadrupole mass spectrometry, thereby offering unparalleled advantages in terms of detection, quantification, and identification of analytes. This hybrid approach empowers analysts to achieve exceptional levels of sensitivity and specificity, even in the presence of interfering compounds or complex sample matrices. One of the key drivers behind the proliferation of LC-MS/MS in clinical and research settings is its ability to address the evolving demands for comprehensive and reliable analytical solutions. LC-MS/MS enables simultaneous quantification of multiple analytes within a single sample, facilitating efficient and cost-effective analysis while maximizing throughput and productivity. Although the initial investment and operational costs associated with LC-MS/MS instrumentation may be relatively high, the benefits it offers in terms of sensitivity, specificity, and efficiency far outweigh the associated expenses.


Download Sample Report

Regional Insights

Based on region, the mycotoxin testing market is segmented into North America, Europe, Asia Pacific, South America, and MEA. Europe (EU) is expected to lead the global mycotoxin testing market due to the implementation of stringent regulations pertaining to animal feed. The European Feed and Food Ingredient Safety Certification plays a crucial role in regulating the animal feed market within the region. Growth in Asia-Pacific is anticipated to be driven by the increasing consumer awareness regarding food ingredients and the growing emphasis of regional governments on conducting comprehensive tests before introducing products to the market. The presence of rigorous food safety regulations established by the US Food and Drugs Administration department is likely to propel revenue growth in North America to unprecedented levels. One of the key drivers for the current growth is the stringent regulations in countries such as Germany, the US, France, and the UK. The UK exhibits the slowest growth rate in the European region. However, the Asia Pacific region is expected to experience a significant boost in the mycotoxin testing market in the coming years due to rapid urbanization. The market is currently constrained by the lack of food control systems, bacterial detection devices, and the casual attitude of developing economies towards high R&D costs. Nevertheless, these factors present opportunities for further development and growth in the mycotoxin market.

Recent Developments

  • In May 2023, Neogen Corporation unveiled its latest offerings, introducing two innovative assays tailored to detect natural toxins: Reveal Q+ for DON EndPoint and Reveal Q+ for Aflatoxin EndPoint. These cutting-edge Reveal Q+ EndPoint assays represent a significant advancement in toxin detection technology, providing user-friendly quantitative lateral flow tests capable of delivering precise results within minutes. Engineered for seamless integration with Neogen's state-of-the-art Raptor® Solo Platform, these assays cater to environments where streamlined workflow efficiency is paramount. With their rapid and accurate performance, these assays empower businesses to swiftly identify and mitigate the risks posed by natural toxins, ensuring product safety and compliance with regulatory standards

Key Market Players

  • SGS S.A.
  • Bureau Veritas SA
  • Eurofins Scientific SE
  • Intertek Group plc
  • Mérieux NutriSciences Corporation
  • ALS Limited
  • Neogen Corporation
  • AsureQuality Ltd.
  • Charm Sciences, Inc.
  • Premier Analytical Services 

 

By Type

By Technology

By Sample

By End User

By Region
  • Aflatoxin
  • Deoxynivalenol
  • Ochratoxins
  • Fumonisins
  • Others
  • HPLC-based
  • LC-MS/MS-based
  • Immunoassay-based
  • Others
  • Food
  • Feed
  • Research Lab
  • Research Institutes
  • Food Testing Industries
  • Feed Testing Industries
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Mycotoxin Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Mycotoxin Testing Market, By Type:

o   Aflatoxin

o   Deoxynivalenol

o   Ochratoxins

o   Fumonisins

o   Others

  • Mycotoxin Testing Market, By Technology:

o   HPLC-based

o   LC-MS/MS-based

o   Immunoassay-based

o   Others

  • Mycotoxin Testing Market, By Sample:

o   Food

o   Feed

  • Mycotoxin Testing Market, By End User:

o   Research Lab

o   Research Institutes

o   Food Testing Industries

o   Feed Testing Industries

o   Others

  • Mycotoxin Testing Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mycotoxin Testing Market.

Available Customizations:

Global Mycotoxin Testing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Mycotoxin Testing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validations

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Mycotoxin Testing Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Type (Aflatoxin, Deoxynivalenol, Ochratoxins, Fumonisins, Others)

5.2.2.    By Technology (HPLC-based, LC-MS/MS-based, Immunoassay-based, Others)

5.2.3.    By Sample (Food, Feed)

5.2.4.    By End User (Research Lab, Research Institutes, Food Testing Industries, Feed Testing Industries and Others)

5.2.5.    By Region

5.2.6.    By Company (2023)

5.3.  Market Map

6.    North America Mycotoxin Testing Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Type

6.2.2.    By Technology

6.2.3.    By Sample

6.2.4.    By End User

6.2.5.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States Mycotoxin Testing Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.            By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.            By Type

6.3.1.2.2.            By Technology

6.3.1.2.3.            By Sample

6.3.1.2.4.            By End User

6.3.2.    Canada Mycotoxin Testing Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.            By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.            By Type

6.3.2.2.2.            By Technology

6.3.2.2.3.            By Sample

6.3.2.2.4.            By End User

6.3.3.    Mexico Mycotoxin Testing Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.            By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.            By Type

6.3.3.2.2.            By Technology

6.3.3.2.3.            By Sample

6.3.3.2.4.            By End User

7.    Europe Mycotoxin Testing Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Type

7.2.2.    By Technology

7.2.3.    By Sample

7.2.4.    By End User

7.2.5.    By Country

7.3.  Europe: Country Analysis

7.3.1.    Germany Mycotoxin Testing Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.            By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.            By Type

7.3.1.2.2.            By Technology

7.3.1.2.3.            By Sample

7.3.1.2.4.            By End User

7.3.2.    United Kingdom Mycotoxin Testing Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.            By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.            By Type

7.3.2.2.2.            By Technology

7.3.2.2.3.            By Sample

7.3.2.2.4.            By End User

7.3.3.    Italy Mycotoxin Testing Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.            By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.            By Type

7.3.3.2.2.            By Technology

7.3.3.2.3.            By Sample

7.3.3.2.4.            By End User

7.3.4.    France Mycotoxin Testing Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.            By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.            By Type

7.3.4.2.2.            By Technology

7.3.4.2.3.            By Sample

7.3.4.2.4.            By End User

7.3.5.    Spain Mycotoxin Testing Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.            By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.            By Type

7.3.5.2.2.            By Technology

7.3.5.2.3.            By Sample

7.3.5.2.4.            By End User

8.    Asia-Pacific Mycotoxin Testing Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Type

8.2.2.    By Technology

8.2.3.    By Sample

8.2.4.    By End User

8.2.5.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China Mycotoxin Testing Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.            By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.            By Type

8.3.1.2.2.            By Technology

8.3.1.2.3.            By Sample

8.3.1.2.4.            By End User

8.3.2.    India Mycotoxin Testing Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.            By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.            By Type

8.3.2.2.2.            By Technology

8.3.2.2.3.            By Sample

8.3.2.2.4.            By End User

8.3.3.    Japan Mycotoxin Testing Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.            By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.            By Type

8.3.3.2.2.            By Technology

8.3.3.2.3.            By Sample

8.3.3.2.4.            By End User

8.3.4.    South Korea Mycotoxin Testing Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.            By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.            By Type

8.3.4.2.2.            By Technology

8.3.4.2.3.            By Sample

8.3.4.2.4.            By End User

8.3.5.    Australia Mycotoxin Testing Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.            By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.            By Type

8.3.5.2.2.            By Technology

8.3.5.2.3.            By Sample

8.3.5.2.4.            By End User

9.    South America Mycotoxin Testing Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Type

9.2.2.    By Technology

9.2.3.    By Sample

9.2.4.    By End User

9.2.5.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Mycotoxin Testing Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.            By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.            By Type

9.3.1.2.2.            By Technology

9.3.1.2.3.            By Sample

9.3.1.2.4.            By End User

9.3.2.    Argentina Mycotoxin Testing Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.            By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.            By Type

9.3.2.2.2.            By Technology

9.3.2.2.3.            By Sample

9.3.2.2.4.            By End User

9.3.3.    Colombia Mycotoxin Testing Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.            By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.            By Type

9.3.3.2.2.            By Technology

9.3.3.2.3.            By Sample

9.3.3.2.4.            By End User

10.  Middle East and Africa Mycotoxin Testing Market Outlook

10.1.            Market Size & Forecast         

10.1.1. By Value

10.2.            Market Share & Forecast

10.2.1. By Type

10.2.2. By Technology

10.2.3. By Sample

10.2.4. By End User

10.2.5. By Country

10.3.            MEA: Country Analysis

10.3.1. South Africa Mycotoxin Testing Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Type

10.3.1.2.2.         By Technology

10.3.1.2.3.         By Sample

10.3.1.2.4.         By End User

10.3.2. Saudi Arabia Mycotoxin Testing Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Type

10.3.2.2.2.         By Technology

10.3.2.2.3.         By Sample

10.3.2.2.4.         By End User

10.3.3. UAE Mycotoxin Testing Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Type

10.3.3.2.2.         By Technology

10.3.3.2.3.         By Sample

10.3.3.2.4.         By End User

11.  Market Dynamics

11.1.            Drivers

11.2.            Challenges

12.  Market Trends & Developments

12.1.            Recent Development

12.2.            Mergers & Acquisitions

12.3.            Product Launches

13.  Global Mycotoxin Testing Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.            Competition in the Industry

14.2.            Potential of New Entrants

14.3.            Power of Suppliers

14.4.            Power of Customers

14.5.            Threat of Substitute Products

15.  Competitive Landscape

15.1.            SGS S.A.

15.1.1. Business Overview

15.1.2. Company Snapshot

15.1.3. Products & Services

15.1.4. Financials (As Reported)

15.1.5. Recent Developments

15.1.6. Key Personnel Details

15.1.7. SWOT Analysis

15.2.            Bureau Veritas SA

15.3.            Eurofins Scientific SE

15.4.            Intertek Group plc

15.5.            Mérieux NutriSciences Corporation

15.6.            ALS Limited

15.7.            Neogen Corporation

15.8.            AsureQuality Ltd.

15.9.            Charm Sciences, Inc.

15.10.         Premier Analytical Services

16.  Strategic Recommendations

17.  About Us & Disclaimer 

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Mycotoxin Testing Market was estimated to be USD 1247.19 Million in 2023.

down-arrow

In 2023, the aflatoxins segment may dominate the global market as countries upgrade their systems and infrastructure to control and prevent regional population exposure to carcinogenic substances.

down-arrow

The European region is expected to dominate the global mycotoxin testing market in the coming years, in line with the trend observed since 2023.

down-arrow

Rising healthcare concerns and growing stringent food safety regulations are the major drivers for the Global Mycotoxin Testing Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Evaporated Milk Market to Grow with a CAGR of 2.54% through 2029

Nov, 2024

The global Evaporated Milk Market is expanding, driven by growing consumer demand for convenience and shelf-stable products, rising interest in dairy-based beverages and desserts, and expanding middl

Why Choose Us